sefulness of recommbinant thrombomodulin (rTM) in the prevention for hematopoietic stem cell transplantation related complication: multicenter joint research project
Not Applicable
Recruiting
- Conditions
- Hematopoietic stem cell transplantation
- Registration Number
- JPRN-UMIN000030426
- Lead Sponsor
- Kansai Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1. severe complications 2. contraindication of rTM 3. sensitivity for rTM 4. eGFR < 30mL/min/1.73m2 5. pregnancy, rectation period 6. inappropriate patients
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Comparison between two groups for hematopoietic stem cell transplantation-related complication in periods from day 0 to day 28
- Secondary Outcome Measures
Name Time Method Comparison between two groups for some biomarkers in periods from day 0 to day 28